|
|
(5 intermediate revisions by 2 users not shown) |
Line 307: |
Line 307: |
| | | |
| <div class="figure medium"> | | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/d/d4/T--Bielefeld-CeBiTec--CytidineCDA.svg"> | + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/2/22/T--Bielefeld-CeBiTec--CytidineCDA.png"> |
| <p class="figure subtitle"><b>Figure (2): Enzyme activity assay for the reaction of the cytidine deaminase with cytidine.</b>The reaction took place at room temperatue. Three biological replicates were used each. After the addition of water, the absorbance at 282 nm stayed the same whereas it decreased after the addition of the CDA. </p> | | <p class="figure subtitle"><b>Figure (2): Enzyme activity assay for the reaction of the cytidine deaminase with cytidine.</b>The reaction took place at room temperatue. Three biological replicates were used each. After the addition of water, the absorbance at 282 nm stayed the same whereas it decreased after the addition of the CDA. </p> |
| </div> | | </div> |
Line 334: |
Line 334: |
| | | |
| <div class="figure medium"> | | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/0/07/T--Bielefeld-CeBiTec--xanthosine_NM.svg"> | + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/9/97/T--Bielefeld-CeBiTec--xanthosine_NM.png"> |
| <p class="figure subtitle"><b>Figure (1): Results of the analysis of the absorbance of xanthosine at different nanometers. </b> <br> AAll measurements made with the Tecan infinite® 200 at room temperature. The difference between a mixture with and without xanthosine (red) can clearly be made up at about 282 nm.</p> | | <p class="figure subtitle"><b>Figure (1): Results of the analysis of the absorbance of xanthosine at different nanometers. </b> <br> AAll measurements made with the Tecan infinite® 200 at room temperature. The difference between a mixture with and without xanthosine (red) can clearly be made up at about 282 nm.</p> |
| </div> | | </div> |
Line 346: |
Line 346: |
| | | |
| <div class="figure medium"> | | <div class="figure medium"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/8/86/T--Bielefeld-CeBiTec--XanthosineCDA.svg"> | + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/d/d4/T--Bielefeld-CeBiTec--XanthosineCDA.png"> |
| <p class="figure subtitle"><b>Figure (3): Enzyme activity assay for the reaction of the cytidine deaminase with xanthosine as a substrate.</b>The reaction was set up at room temperature, using three biological replicates each. After adding CDA to the reaction mixture, a slight decrease in the absorbance at 282 nm was visible. However, as there is also a very small decrease for the addition of water, no significant difference was observed.</p> | | <p class="figure subtitle"><b>Figure (3): Enzyme activity assay for the reaction of the cytidine deaminase with xanthosine as a substrate.</b>The reaction was set up at room temperature, using three biological replicates each. After adding CDA to the reaction mixture, a slight decrease in the absorbance at 282 nm was visible. However, as there is also a very small decrease for the addition of water, no significant difference was observed.</p> |
| </div> | | </div> |
Line 389: |
Line 389: |
| <div class="half left"> | | <div class="half left"> |
| <div class="figure hundred"> | | <div class="figure hundred"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/f/f2/T--Bielefeld-CeBiTec--GMPSGeneSyn.svg"> | + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/6/66/T--Bielefeld-CeBiTec--GMPSGeneSyn.png"> |
| <p class="figure subtitle"><b>Figure (5): Enzyme activity assay of iso-form 2 of the guanosine monophosphate synthetases.</b>The reaction was set up at room temperature using three biological replicates. A significant decrease in the absorption at 290 nm can be made up after the addition of the synthetized GMPS whereas the negative control with water stays at the same absorption. </p> | | <p class="figure subtitle"><b>Figure (5): Enzyme activity assay of iso-form 2 of the guanosine monophosphate synthetases.</b>The reaction was set up at room temperature using three biological replicates. A significant decrease in the absorption at 290 nm can be made up after the addition of the synthetized GMPS whereas the negative control with water stays at the same absorption. </p> |
| </div> | | </div> |
Line 395: |
Line 395: |
| <div class="half right"> | | <div class="half right"> |
| <div class="figure hundred"> | | <div class="figure hundred"> |
− | <img class="figure image" src="https://static.igem.org/mediawiki/2017/7/7f/T--Bielefeld-CeBiTec--GMPSSelf.svg"> | + | <img class="figure image" src="https://static.igem.org/mediawiki/2017/0/0c/T--Bielefeld-CeBiTec--GMPSSelf.png"> |
| <p class="figure subtitle"><b>Figure (6):Enzyme activity assay of iso-form1 of the guanosine monophosphate synthetases.</b>Three biological replicates were used. The reaction was set up at room temperature. A significant decrease in the absorption at 290 nm can be made up after the addition of the GMPS whereas the negative control with water stays at the same absorption. </p> | | <p class="figure subtitle"><b>Figure (6):Enzyme activity assay of iso-form1 of the guanosine monophosphate synthetases.</b>Three biological replicates were used. The reaction was set up at room temperature. A significant decrease in the absorption at 290 nm can be made up after the addition of the GMPS whereas the negative control with water stays at the same absorption. </p> |
| </div> | | </div> |
| </div> | | </div> |
− |
| |
| </div> | | </div> |
| + | |
| + | <div class="article"> |
| As described earlier, it took some time to figure out the right requirements for the HPLC-MicroTofQ measurements, since iso-GMP and GMP have the exact same mass and are thus only separable by their structure. However, with the method chosen in the end, it was possible to identify analytes that seem to represent iso-GMP. Therefore, at first, the general substances within the reaction mix had to be figured out to ensure that only those representing GMP/iso-GMP will be included in the analyses. The general analysis of all substances included showed significant values for all the interesting substrates and products that should be within the reaction mix, including AMP, ADP and ATP, some remaining traces of XMP and of course GMP/iso-GMP (Figures 7 and 8). | | As described earlier, it took some time to figure out the right requirements for the HPLC-MicroTofQ measurements, since iso-GMP and GMP have the exact same mass and are thus only separable by their structure. However, with the method chosen in the end, it was possible to identify analytes that seem to represent iso-GMP. Therefore, at first, the general substances within the reaction mix had to be figured out to ensure that only those representing GMP/iso-GMP will be included in the analyses. The general analysis of all substances included showed significant values for all the interesting substrates and products that should be within the reaction mix, including AMP, ADP and ATP, some remaining traces of XMP and of course GMP/iso-GMP (Figures 7 and 8). |
| + | </div> |
| + | |
| <div class="contentline"> | | <div class="contentline"> |
| <div class="half left"> | | <div class="half left"> |
Line 416: |
Line 419: |
| </div> | | </div> |
| | | |
− | | + | <div class="article"> |
| We then compared the resulting form of GMP with a GMP-standard (10^-5 diluted solution) and the exact measurements of the HPLC. For both, isoform 2 and isoform 1 of GMPS the peaks of the substance’s flow-through found at the molecular mass of GMP and iso-GMP (approximately 363.22 g/mol, in the graph at approximately 362 g/mol because of the missing H due to the measurement method) were significantly shifted to the right compared to the standard. Thus, the form of GMP that is created with the enzyme reactions of the two isoforms of GMPS and the gene synthesis has to be another form of GMP, most likely iso-GMP. (Figure 9) | | We then compared the resulting form of GMP with a GMP-standard (10^-5 diluted solution) and the exact measurements of the HPLC. For both, isoform 2 and isoform 1 of GMPS the peaks of the substance’s flow-through found at the molecular mass of GMP and iso-GMP (approximately 363.22 g/mol, in the graph at approximately 362 g/mol because of the missing H due to the measurement method) were significantly shifted to the right compared to the standard. Thus, the form of GMP that is created with the enzyme reactions of the two isoforms of GMPS and the gene synthesis has to be another form of GMP, most likely iso-GMP. (Figure 9) |
| + | </div> |
| | | |
− | <div class="figure seventy"> | + | <div class="figure medium"> |
| <img class="figure image" src="https://static.igem.org/mediawiki/2017/c/c7/T--Bielefeld-CeBiTec--HPLC_GMPvsISOGMP.png"> | | <img class="figure image" src="https://static.igem.org/mediawiki/2017/c/c7/T--Bielefeld-CeBiTec--HPLC_GMPvsISOGMP.png"> |
| <p class="figure subtitle"><b>Figure (9): HPLC-MicroTofQ measurement comparing the GMP standard and the reaction products’ flow-through. </b> In red the product of isoform 2 of GMPS. In blue, the one found for isoform 1 of GMPS, in green the standard. Even though the standard as well as the mixtures contained compounds that have the same molecular mass, they show different behaviors on the HPLC. The ordinary GMP was significantly faster than the one generated in the enzyme reactions. Thus, the form of GMP that results from the reactions is likely to be iso-GMP. </p> | | <p class="figure subtitle"><b>Figure (9): HPLC-MicroTofQ measurement comparing the GMP standard and the reaction products’ flow-through. </b> In red the product of isoform 2 of GMPS. In blue, the one found for isoform 1 of GMPS, in green the standard. Even though the standard as well as the mixtures contained compounds that have the same molecular mass, they show different behaviors on the HPLC. The ordinary GMP was significantly faster than the one generated in the enzyme reactions. Thus, the form of GMP that results from the reactions is likely to be iso-GMP. </p> |
| </div> | | </div> |
| | | |
| + | <article> |
| In conclusion, we did not only figure out the synthesis pathways in <i>Croton tiglium</i> but could even recreate a part of it, showing that the enzymes expressed in <i>Croton tiglium</i> are more likely to generate a different form of GMP (presumably iso-GMP). | | In conclusion, we did not only figure out the synthesis pathways in <i>Croton tiglium</i> but could even recreate a part of it, showing that the enzymes expressed in <i>Croton tiglium</i> are more likely to generate a different form of GMP (presumably iso-GMP). |
| </article> | | </article> |
Line 437: |
Line 442: |
| | | |
| <div class="contentbox"> | | <div class="contentbox"> |
− | <div class="content"> | + | <div class="content"></div> |
− |
| + | |
| <h2> References </h2> | | <h2> References </h2> |
− |
| |
− |
| |
− | <!-- Normaler Text -->
| |
| <article> | | <article> |
| <b>Abbott, J., Newell, J., Lightcap, C. <i>et al.</i></b>(2006) The Effects of Removing the GAT Domain from E.coli GMP Synthetase. <b>25</b> 384<br> | | <b>Abbott, J., Newell, J., Lightcap, C. <i>et al.</i></b>(2006) The Effects of Removing the GAT Domain from E.coli GMP Synthetase. <b>25</b> 384<br> |
| <b>Cohen, R.M., Wolfenden, R.</b> (1971). Cytidine Deaminase from <i>E.coli</i> – Purificarion Properties and Inhibiton by the potential transition state analog 3,4,5,6-tetrahydrouridine. The Journal of Biological Chemistry. <b>25</b><br> | | <b>Cohen, R.M., Wolfenden, R.</b> (1971). Cytidine Deaminase from <i>E.coli</i> – Purificarion Properties and Inhibiton by the potential transition state analog 3,4,5,6-tetrahydrouridine. The Journal of Biological Chemistry. <b>25</b><br> |
| <b>Zalkin, H </b>(1971), GMP sythesis | | <b>Zalkin, H </b>(1971), GMP sythesis |
| + | </article> |
| + | </div> |
| | | |
− |
| |
− | </article>
| |
− |
| |
− | </div>
| |
| </div> | | </div> |
| | | |
| </div> | | </div> |
− |
| |
− |
| |
− |
| |
− |
| |
− |
| |
− |
| |
− |
| |
− |
| |
| | | |
| </body> | | </body> |